A review of 685 rhytidectomies: a new method of analysis based on digitally processed photographs with computer-processed data.
暂无分享,去创建一个
[1] R. Goldwyn. AIDS, aesthetic surgery, and the plastic surgeon. , 2004, Plastic and reconstructive surgery.
[2] N. Buss,et al. Protease inhibitors in HIV infection , 1999, BMJ.
[3] F. Bergmann,et al. Gynaecomastia in a male patient during protease inhibitor treatment for acute HIV disease. , 1998, AIDS.
[4] D. Cooper,et al. Lipodystrophy Associated with an HIV-Protease Inhibitor , 1998 .
[5] R. Stricker,et al. Fat accumulation and HIV-1 protease inhibitors , 1998, The Lancet.
[6] K. Mclean,et al. Disorders of fat distribution in HIV infection , 1998, International journal of STD & AIDS.
[7] S. Hamra. The zygorbicular dissection in composite rhytidectomy: an ideal midface plane. , 1998, Plastic and reconstructive surgery.
[8] S. Hamra. Frequent face lift sequelae: hollow eyes and the lateral sweep: cause and repair. , 1998, Plastic and reconstructive surgery.
[9] F. Goebel,et al. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV‐1‐infected patients , 1998, AIDS.
[10] Y. Mishriki. A baffling case of bulging belly , 1998 .
[11] D. Cooper,et al. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance , 1998, The Lancet.
[12] D. Cooper,et al. Abnormal fat distribution and use of protease inhibitors , 1998, The Lancet.
[13] K. Wong,et al. Abnormal fat distribution and use of protease inhibitors , 1998, The Lancet.
[14] C. Flexner. HIV-protease inhibitors. , 1998, The New England journal of medicine.
[15] T. Brown,et al. HIV risk behavioral surveillance: a methodology for monitoring behavioral trends. , 1998, AIDS.
[16] K. Miller,et al. Visceral abdominal-fat accumulation associated with use of indinavir , 1998, The Lancet.
[17] Morris Schambelan,et al. “Buffalo hump” in men with HIV-1 infection , 1998, The Lancet.
[18] R. Stricker,et al. Weight gain associated with protease inhibitor therapy in HIV-infected patients. , 1998, Research in virology.
[19] J. Leonard,et al. Decrease of HIV‐1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine , 1998, AIDS.
[20] J. Montastruc,et al. Lipodystrophia with protease inhibitors in HIV patients. , 1997, Therapie.
[21] B. Friedland. The Americans with Disabilities Act: should it compel cosmetic treatment for HIV-positive individuals? , 1997, Plastic and reconstructive surgery.
[22] R. Brettle,et al. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals , 1997, The Lancet.
[23] J. Kahn,et al. HIV-1 protease inhibitors. A review for clinicians. , 1997 .
[24] S. Hamra. Arcus Marginalis Release and Orbital Fat Preservation in Midface Rejuvenation , 1995, Plastic and reconstructive surgery.
[25] R. Narins. Liposuction surgery for a buffalo hump caused by Cushing's disease. , 1989, Journal of the American Academy of Dermatology.
[26] W. Coleman. Noncosmetic applications of liposuction. , 1988, The Journal of dermatologic surgery and oncology.
[27] D. Sarwer,et al. A retrospective study of changes in physical symptoms and body image after reduction mammaplasty. , 1999, Plastic and reconstructive surgery.
[28] S. Hamra. The role of orbital fat preservation in facial aesthetic surgery. A new concept. , 1996, Clinics in plastic surgery.
[29] H. Perrot. [Localized lipo-atrophies]. , 1988, Annales de dermatologie et de venereologie.